MED
MEDIFAST INC
12.00$
+0.0%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.4% | +0.6% | +9.8% | +66.1% | +42.4% | +31.0% | +63.2% | +4.8% | -32.9% | -43.8% | -36.0% | |
| – | -6.1% | -3.6% | +7.1% | +64.2% | +46.0% | +34.1% | +68.1% | +15.0% | -35.3% | -46.7% | -29.9% | |
| – | -3.8% | +2.2% | +10.8% | +66.8% | +41.3% | +30.0% | +61.6% | +1.1% | -32.0% | -42.7% | -38.1% | |
| – | +38.5% | +11.1% | +10.0% | +0.0% | +22.7% | +3.7% | +57.1% | +2.3% | +2.2% | +0.0% | – | |
| – | -3.5% | +3.6% | +5.2% | +65.2% | +43.4% | +26.4% | +61.4% | +4.9% | -32.3% | -36.5% | -30.6% | |
| – | -3.5% | +3.6% | +5.2% | +65.2% | +43.4% | +26.4% | +61.7% | +4.9% | -32.0% | -32.0% | -34.5% | |
| – | -5.2% | -6.4% | +47.6% | +74.3% | +31.8% | +47.4% | +61.2% | -14.5% | -31.6% | -97.7% | -593.8% | |
| – | -7.7% | -57.2% | +97.2% | +134.1% | +355.4% | +24.0% | -96.9% | +203.5% | +255.2% | +92.9% | – | |
| – | -6.4% | -8.6% | +48.7% | +74.9% | +30.9% | +45.4% | +61.0% | -14.8% | -30.0% | -97.1% | -248.9% | |
| – | -5.3% | -8.1% | +35.7% | +17.1% | -2.1% | +117.4% | +65.9% | -22.3% | -27.4% | -94.2% | +668.5% | |
| – | +52.2% | -11.1% | +55.4% | +101.3% | +39.7% | +32.0% | +59.5% | -12.5% | -30.8% | -97.9% | -993.0% | |
| – | -6.5% | -9.9% | +35.9% | +67.6% | +30.2% | +47.8% | +57.6% | -12.2% | -27.5% | -88.4% | -70.5% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.